References
- Chen X, Vaughn JM, Yacaman MJ, et al. (2004). Rapid dissolution of high‐potency danazol particles produced by evaporative precipitation into aqueous solution. J Pharmaceut Sci 93:1867–78
- Chow AH, Tong HH, Chattopadhyay P, Shekunov BY. (2007). Particle engineering for pulmonary drug delivery. Pharmaceut Res 24:411–37
- Deutschländer M, Van de Venter M, Roux S, et al. (2009). Hypoglycaemic activity of four plant extracts traditionally used in South Africa for diabetes. J Ethnopharmacol 124:619–24
- Grau M, Kayser O, Müller R. (2000). Nanosuspensions of poorly soluble drugs – reproducibility of small scale production. Int J Pharmaceut 196:155–9
- Hu J, Ng WK, Dong Y, et al. (2011). Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying. Int J Pharmaceut 404:198–204
- Keck CM, Müller RH. (2006). Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharmaceut Biopharmaceut 62:3–16
- Kim S, Ng WK, Dong Y, et al. (2012). Preparation and physicochemical characterization of trans-resveratrol nanoparticles by temperature-controlled antisolvent precipitation. J Food Eng 108:37–42
- Leuner C, Dressman J. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur J Pharmaceut Biopharmaceut 50:47–60
- Majerik V, Charbit G, Badens E, et al. (2007). Bioavailability enhancement of an active substance by supercritical antisolvent precipitation. J Supercrit Fluids 40:101–10
- Merisko-Liversidge EM, Liversidge GG. (2008). Drug nanoparticles: formulating poorly water-soluble compounds. Toxicol Pathol 36:43–8
- Mosharraf M, Nyström C. (2003). Apparent solubility of drugs in partially crystalline systems. Drug Devel Indust Pharmacy 29:603–22
- Müller R, Jacobs C, Kayser O. (2001). Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Adv Drug Deliv Rev 47:3–19
- Patravale V, Kulkarni R. (2004). Nanosuspensions: a promising drug delivery strategy. J Pharmacy Pharmacol 56:827–40
- Perrut M, Jung J, Leboeuf F. (2005). Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes: Part I: micronization of neat particles. Int J Pharmaceut 288:3–10
- Raghavan S, Kiepfer B, Davis A, et al. (2001a). Membrane transport of hydrocortisone acetate from supersaturated solutions; the role of polymers. Int J Pharmaceut 221:95–105
- Raghavan S, Trividic A, Davis A, Hadgraft J. (2001b). Crystallization of hydrocortisone acetate: influence of polymers. Int J Pharmaceut 212:213–21
- Shah P. (2006). Use of nanotechnologies for drug delivery. MRS Bull 31:894–9
- Tang J-J, Li J-G, Qi W, et al. (2011). Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques. Cell Metabol 13:44–56
- Vasconcelos T, Sarmento B, Costa P. (2007). Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today 12:1068–75
- Viçosa A, Letourneau J-J, Espitalier F, Inês Ré M. (2012). An innovative antisolvent precipitation process as a promising technique to prepare ultrafine rifampicin particles. J Crystal Growth 342:80–7
- Zhao X, Shan C, Zu Y, et al. (2013). Preparation, characterization, and evaluation in vivo of ins-SiO2-HP55 (Insulin-loaded silica coating HP55) for oral delivery of insulin. Int J Pharmaceut 454:278–84